Transport
Central Iowa Hospital Corporation
Central Iowa Hospital Corporation was paid $14.72M by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.
33Billing provider infoCENTRAL IOWA HOSPITAL CORPORATION
DES MOINES, IA 50316
DES MOINES, IA 50316
33aNPI1356433049assigned 09/29/2006
33bProvider typeAmbulance
28Total paid$14.72M
24GClaims176,478
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulance providers in Iowa
Rank by total paid#3 of 45
Median peer was paid$85K
This provider vs. median173×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official ALLEN, PATRICIA controls 18+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 31,662 | $2.62M | |
| 2019 | 32,020 | $2.05M | |
| 2020 | 22,061 | $1.39M | |
| 2021 | 26,626 | $1.98M | |
| 2022 | 26,243 | $2.18M | |
| 2023 | 24,908 | $2.20M | |
| 2024incomplete | 12,958 | $2.28M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 9,991 | 9,264 | $2.46M |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 15% | 999 | 986 | $2.26M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 6,022 | 5,418 | $1.90M |
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | 6.7% | 11,433 | 1,642 | $981K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 6.5% | 6,179 | 989 | $954K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.1% | 5,655 | 5,216 | $895K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 6.0% | 1,794 | 1,732 | $889K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5.4% | 43,943 | 41,229 | $788K |
| D1206 | Topical application of fluoride varnish | 4.9% | 1,474 | 1,430 | $726K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.6% | 2,692 | 2,424 | $378K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 2.2% | 5,221 | 1,453 | $330K |
| S9480 | Intensive outpatient psychiatric services, per diem | 2.2% | 2,999 | 548 | $326K |
68 more codes
| D1120 | Dental cleaning, child | 2.0% | 566 | $293K |
| D1351 | Sealant - per tooth | 1.8% | 557 | $272K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.8% | 3,065 | $265K |
| D7140 | Extraction, erupted tooth or exposed root | 1.7% | 222 | $254K |
| 90791 | Psychiatric diagnostic evaluation | 1.4% | 1,697 | $204K |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 288 | $138K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 899 | $87K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 210 | $67K |
| H0017 | Behavioral health; residential (hospital residential treatment program), without room and board, per diem | <1% | 344 | $48K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 102 | $36K |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,723 | $36K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 178 | $19K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 170 | $17K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 203 | $14K |
| D2934 | <1% | 26 | $14K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,919 | $12K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 255 | $9K |
| 95913 | <1% | 16 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,569 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,890 | $4K |
| J0485 | Injection, belatacept, 1 mg | <1% | 16 | $4K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 51 | $4K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 14 | $3K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,639 | $3K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,977 | $3K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,665 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,236 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,037 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,916 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,245 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 7,601 | $1K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 14 | $706.19 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $651.04 |
| 81025 | <1% | 225 | $602.91 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 807 | $575.04 |
| 81001 | <1% | 5,337 | $226.73 | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 28 | $106.36 |
| 83690 | <1% | 753 | $36.19 | |
| 83735 | <1% | 256 | $12.50 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 52 | $11.38 |
| 85027 | <1% | 186 | $10.27 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 12 | $8.80 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 12 | $4.87 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 13 | $3.21 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,619 | $3.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 14 | $3.00 |
| 84484 | <1% | 117 | $2.58 | |
| 80076 | <1% | 73 | $1.88 | |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 62 | $1.60 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | <1% | 38 | $0.45 |
| 82077 | 0% | 111 | $0.00 | |
| 96127 | 0% | 236 | $0.00 | |
| 87581 | 0% | 31 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 108 | $0.00 |
| 95886 | 0% | 33 | $0.00 | |
| 83605 | 0% | 19 | $0.00 | |
| 87486 | 0% | 31 | $0.00 | |
| 80179 | 0% | 58 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 279 | $0.00 |
| 87400 | 0% | 60 | $0.00 | |
| D2929 | 0% | 14 | $0.00 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 60 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 31 | $0.00 |
| 80305 | 0% | 25 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 15 | $0.00 |
| 80143 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALLEN, PATRICIA (CFO)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.